BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 32986435)

  • 1. Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
    Manta K; Papakyriakopoulou P; Chountoulesi M; Diamantis DA; Spaneas D; Vakali V; Naziris N; Chatziathanasiadou MV; Andreadelis I; Moschovou K; Athanasiadou I; Dallas P; Rekkas DM; Demetzos C; Colombo G; Banella S; Javornik U; Plavec J; Mavromoustakos T; Tzakos AG; Valsami G
    Mol Pharm; 2020 Nov; 17(11):4241-4255. PubMed ID: 32986435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal powders of quercetin-β-cyclodextrin derivatives complexes with mannitol/lecithin microparticles for Nose-to-Brain delivery: In vitro and ex vivo evaluation.
    Papakyriakopoulou P; Manta K; Kostantini C; Kikionis S; Banella S; Ioannou E; Christodoulou E; Rekkas DM; Dallas P; Vertzoni M; Valsami G; Colombo G
    Int J Pharm; 2021 Sep; 607():121016. PubMed ID: 34411652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion complexes of quercetin with three β-cyclodextrins derivatives at physiological pH: spectroscopic study and antioxidant activity.
    Liu M; Dong L; Chen A; Zheng Y; Sun D; Wang X; Wang B
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Nov; 115():854-60. PubMed ID: 23892509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
    Zheng Y; Haworth IS; Zuo Z; Chow MS; Chow AH
    J Pharm Sci; 2005 May; 94(5):1079-89. PubMed ID: 15793810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
    Patel SG; Rajput SJ
    AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
    Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS
    Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterisation of ecdysterone/hydroxypropyl-Β-cyclodextrin inclusion complex with enhanced oral and transdermal bioavailability.
    Wang L; Li S; Cai H; Liu X; Feng T; Zhao X
    J Microencapsul; 2022 Mar; 39(2):145-155. PubMed ID: 35311602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
    Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
    Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.
    Semcheddine F; Guissi Nel I; Liu X; Wu Z; Wang B
    AAPS PharmSciTech; 2015 Jun; 16(3):704-15. PubMed ID: 25511809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity.
    Yurtdaş-Kırımlıoğlu G
    Drug Dev Ind Pharm; 2021 Aug; 47(8):1261-1278. PubMed ID: 34606394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spray-dried mucoadhesive microparticles based on S-protected thiolated hydroxypropyl-β-cyclodextrin for budesonide nasal delivery.
    Racaniello GF; Laquintana V; Summonte S; Lopedota A; Cutrignelli A; Lopalco A; Franco M; Bernkop-Schnürch A; Denora N
    Int J Pharm; 2021 Jun; 603():120728. PubMed ID: 34029665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis-
    Han D; Han Z; Liu L; Wang Y; Xin S; Zhang H; Yu Z
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.
    Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
    Liu M; Cao W; Sun Y; He Z
    Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole.
    Che J; Wu Z; Shao W; Guo P; Lin Y; Pan W; Zeng W; Zhang G; Wu C; Xu Y
    Eur J Pharm Biopharm; 2015 Jun; 93():136-48. PubMed ID: 25845772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation.
    Zhao Y; Sun C; Shi F; Firempong CK; Yu J; Xu X; Zhang W
    Pharm Biol; 2016; 54(1):130-8. PubMed ID: 25853954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquiritin-Hydroxypropyl-Beta-Cyclodextrin Inclusion Complex: Preparation, Characterization, Bioavailability and Antitumor Activity Evaluation.
    Wang Q; Zhang K; Weng W; Chen L; Wei C; Bao R; Adu-Frimpong M; Cao X; Yu Q; Shi F; Toreniyazov E; Ji H; Xu X; Yu J
    J Pharm Sci; 2022 Jul; 111(7):2083-2092. PubMed ID: 35367247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
    Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-dependent complexation of hydroxypropyl-beta-cyclodextrin with chlorin e6: effect on solubility and aggregation in relation to photodynamic efficacy.
    Paul S; Heng PW; Chan LW
    J Pharm Pharmacol; 2016 Apr; 68(4):439-49. PubMed ID: 26946047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.